Functional consequences of the somatopause and its treatment
- 1 August 1997
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 7 (1) , 73-76
Abstract
The decline in the function of the growth hormone-releasing hormone, growth hormone, insulin-like growth factor (GHRH-GH-IGF) axis has been termed the somatopause. Many of the catabolic sequelae seen in normal aging has been attributed to this decrease in circulating GH and IGF-I. In order to provide hormone replacement therapy for the somatopause, elderly subjects have been treated with GH, IGF-I, or both hormones together. Whereas numerous beneficial effects on body composition, strength, and quality of life have been reported in some studies, other studies have reported only marginal functional imporvements. Moreover, it is clear that both hormones can cause significant morbidity.Keywords
This publication has 42 references indexed in Scilit:
- Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly womenJournal of Bone and Mineral Research, 1995
- Growth hormone and the heartEndocrine Reviews, 1994
- Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly womenThe Journal of Clinical Endocrinology & Metabolism, 1994
- High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndromeThe Journal of Clinical Endocrinology & Metabolism, 1994
- Age-dependent effect of resistance exercise on growth hormone secretion in peopleThe Journal of Clinical Endocrinology & Metabolism, 1992
- Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humansThe Journal of Clinical Endocrinology & Metabolism, 1992
- Reversal of diet-induced catabolism by infusion of recombinant insulin- like growth factor-I in humansThe Journal of Clinical Endocrinology & Metabolism, 1992
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Impaired growth hormone secretion in the adult population: relation to age and adiposity.Journal of Clinical Investigation, 1981